Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (161)

2024

  1. 3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release

    Drug Delivery and Translational Research

  2. BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury

    Biomedicine and Pharmacotherapy, Vol. 174

  3. High enhancement of sensitivity and reproducibility in label-free SARS-CoV-2 detection with graphene field-effect transistor sensors through precise surface biofunctionalization control

    Biosensors and Bioelectronics, Vol. 250

  4. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

  5. Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer

    Biomedical Materials (Bristol), Vol. 19, Núm. 3

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  3. Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug

    Pharmaceutics, Vol. 15, Núm. 2

  4. Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition

    Redox Biology, Vol. 63

  5. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  6. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  7. Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer

    Chemistry - A European Journal, Vol. 29, Núm. 60

  8. Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging Assessments in a Mouse Model of Implant-Related Bone and Joint Staphylococcus aureus Infection

    Microbiology spectrum, Vol. 11, Núm. 3, pp. e0454022

  9. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

    JHEP Reports, Vol. 5, Núm. 8

2022

  1. Broad virus inactivation using inorganic micro/nano-particulate materials

    Materials Today Bio, Vol. 13

  2. Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability

    Pharmaceutics, Vol. 14, Núm. 1

  3. Implantable Electrospun Nanofibers with Wound-Healing Capabilities in the Reduction of Pressure Ulcers

    ACS Applied Polymer Materials

  4. In vivo production of fluorine-18 in a chicken egg tumor model of breast cancer for proton therapy range verification

    Scientific Reports, Vol. 12, Núm. 1

  5. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

    Hepatology, Vol. 75, Núm. 3, pp. 550-566

  6. Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight

    Metabolism: Clinical and Experimental, Vol. 137